专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

US20100041891A1 AMIDE COMPOUND 审中-公开
标题翻译：酰胺化合物
公开(公告)号：US20100041891A1
公开(公告)日：2010-02-18
申请号：US12539559
申请日：2009-08-11
申请人： Masaki Setoh , Mitsunori Kouno , Yuhei Miyanohana , Masakuni Kori
发明人： Masaki Setoh , Mitsunori Kouno , Yuhei Miyanohana , Masakuni Kori
IPC分类号： C07D409/06 , C07D235/24 , C07D277/62
CPC分类号： C07D217/04 , C07D209/10 , C07D209/46 , C07D231/56 , C07D235/10 , C07D235/26 , C07D235/28 , C07D235/30 , C07D263/56 , C07D277/64 , C07D277/68 , C07D307/79 , C07D333/54 , C07D401/04 , C07D405/04 , C07D405/12 , C07D407/12 , C07D409/04 , C07D409/06 , C07D409/12 , C07D411/12 , C07D417/12 , C07D471/04 , C07D487/04 , C07D491/048
摘要： A compound having GPR52 agonist activity or a salt thereof is provided.The compound can be provided as a preventive/therapeutic agent for schizophrenia or the like. The compound is represented by the following formula: whereinA represents —CONRa— or —NRaCO—, Ra represents a hydrogen atom or the like, B represents a hydrogen atom or the like, a ring Cy1 represents a six-membered aromatic ring which may have one or more substituents in addition to a group represented by -A-B, a ring Cy2 represents a six-membered ring which may be substituted with a halogen atom or the like, a ring Cy3 represents a five- or six-membered ring which may have one or more substituents; X represents C1-2 alkylene or the like, m represents an integer of 0 to 2, and a ring Cy4 represents a six-membered aromatic ring which may have one or more substituents.
摘要翻译：提供具有GPR52激动剂活性的化合物或其盐。该化合物可以作为精神分裂症等的预防/治疗剂提供。该化合物由下式表示：其中A表示-CONRa-或-NRaCO-，Ra表示氢原子等，B表示氢原子等，环Cy1表示可以含有六元芳环的六元芳环除了由-AB表示的基团之外还具有一个或多个取代基，环Cy2表示可被卤素原子等取代的六元环，环Cy3表示五元或六元环，其可以具有一个或多个取代基; X表示C1-2亚烷基等，m表示0〜2的整数，环Cy4表示可具有一个以上取代基的六元芳香环。

2. 发明申请

US20110130384A1 AMIDE COMPOUND 审中-公开
标题翻译：酰胺化合物
公开(公告)号：US20110130384A1
公开(公告)日：2011-06-02
申请号：US13000570
申请日：2009-06-24
申请人： Masaki Setoh , Yuhei Miyanohana , Mitsunori Kouno
发明人： Masaki Setoh , Yuhei Miyanohana , Mitsunori Kouno
IPC分类号： A61K31/55 , C07D209/04 , A61K31/4045 , C07D471/04 , A61K31/437 , C07D487/04 , A61K31/519 , C07D223/16 , A61P25/18
CPC分类号： C07D209/08 , C07C233/65 , C07C233/78 , C07C235/16 , C07C235/42 , C07C235/48 , C07C237/22 , C07C237/32 , C07C237/34 , C07C255/29 , C07C317/28 , C07C323/42 , C07C2601/02 , C07C2602/08 , C07C2602/10 , C07D209/10 , C07D209/18 , C07D213/81 , C07D223/16 , C07D231/56 , C07D265/36 , C07D277/20 , C07D277/46 , C07D307/14 , C07D307/82 , C07D311/04 , C07D417/12 , C07D471/04 , C07D487/04
摘要： The present invention aims to provide a prophylactic or therapeutic agent for schizophrenia and the like, containing the compound of the present invention having a GPR52 agonist activity. A compound represented by the following formula (I) or a salt thereof: wherein, A is —CONH or the like, B is a hydrogen atom or a substituent, ring Cy1 is a benzene ring or the like, X1, X2 and X3 are each independently —CH═ or —N═ or the like, ring Cy2 is a carbon ring or the like, Z is a carbon atom or a nitrogen atom, L is a bond or the like, n is 1 or 2, Rb is a hydrogen atom or a substituent, and ring Cy3 is a benzene ring or the like.
摘要翻译：本发明旨在提供含有具有GPR52激动剂活性的本发明化合物的精神分裂症等的预防或治疗剂。由下式（I）表示的化合物或其盐：其中A为-CONH等，B为氢原子或取代基，环为Cy1为苯环等，X1，X2，X3为各自独立地为-CH =或-N =等，环Cy2为碳环等，Z为碳原子或氮原子，L为键等，n为1或2，Rb为氢原子或取代基，环Cy3为苯环等。

3. 发明申请

US20090048263A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder 失效
标题翻译：脑/神经元细胞保护剂和睡眠障碍治疗剂
公开(公告)号：US20090048263A1
公开(公告)日：2009-02-19
申请号：US11990385
申请日：2006-08-11
申请人： Takahiro Matsumoto , Masakuni Kori , Mitsunori Kouno
发明人： Takahiro Matsumoto , Masakuni Kori , Mitsunori Kouno
IPC分类号： A61K31/496 , C07D401/02 , C07D413/02 , C07D401/14 , A61K31/501 , A61P25/00 , C07D413/14 , C07D403/02 , C07D409/14
CPC分类号： C07D213/75 , C07D237/20 , C07D261/14 , C07D333/20 , C07D405/14 , C07D409/14 , C07D413/14
摘要： A compound represented by the formula (I) or a salt thereof; and an agent for protecting a brain/neuronal cell or a therapeutic agent for sleep disorder comprising the compound or salt: wherein Z represents an oxygen or sulfur; R1 represents an aryl or heterocyclic group which may be substituted, provided that R1 is not a 3-ethyl-6-methoxy-2-methyl-5-naphthalen-1-yl group; R1a represents a hydrogen atom, a hydrocarbon group which may be substituted, a hydroxyl group or the like; R2 represents a piperidin-1,4-diyl or piperazin-1,4-diyl which may be substituted; R3 represents a bivalent group which is formed by removing two hydrogen atoms from a benzene ring or 6-membered aromatic heterocyclic ring which may have a substituent, provided that R3 is not a pyridazin-3,6-diyl; and R4 represents a group which is formed by removing one hydrogen atom from a benzene ring or 5- to 6-membered heterocyclic ring which may be substituted, provided that the substituent on the heterocyclic ring is not a phenylethyl group which may be substituted when Z is sulfur.
摘要翻译：由式（I）表示的化合物或其盐; 以及用于保护脑/神经元细胞或用于睡眠障碍的治疗剂的药剂，其包含所述化合物或盐：其中Z表示氧或硫; R1表示可被取代的芳基或杂环基，条件是R 1不是3-乙基-6-甲氧基-2-甲基-5-萘-1-基; R 1a表示氢原子，可被取代的烃基，羟基等; R2代表可被取代的哌啶-1,4-二基或哌嗪-1,4-二基; R3表示通过从可以具有取代基的苯环或6元芳族杂环除去2个氢原子而形成的二价基团，条件是R 3不是哒嗪-3,6-二基; 并且R 4表示通过从可以被取代的苯环或5-至6-元杂环除去一个氢原子而形成的基团，条件是杂环上的取代基不是Z时可以被取代的苯基乙基是硫。

4. 发明授权

US07812025B2 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder 失效
标题翻译：脑/神经元细胞保护剂和睡眠障碍治疗剂
公开(公告)号：US07812025B2
公开(公告)日：2010-10-12
申请号：US11990385
申请日：2006-08-11
申请人： Takahiro Matsumoto , Masakuni Kori , Mitsunori Kouno
发明人： Takahiro Matsumoto , Masakuni Kori , Mitsunori Kouno
IPC分类号： A61K31/501 , A61K31/497 , A61K31/44 , C07D237/02 , C07D401/06 , C07D403/06 , C07D413/06 , C07D241/06 , C07D401/02 , C07D213/02
CPC分类号： C07D213/75 , C07D237/20 , C07D261/14 , C07D333/20 , C07D405/14 , C07D409/14 , C07D413/14
摘要： A compound represented by the formula (I) or a salt thereof; and an agent for protecting a brain/neuronal cell or a therapeutic agent for sleep disorder comprising the compound or salt: wherein Z represents an oxygen or sulfur; R1 represents an aryl or heterocyclic group which may be substituted, provided that R1 is not a 3-ethyl-6-methoxy-2-methyl-5-naphthalen-1-yl group; R1a represents a hydrogen atom, a hydrocarbon group which may be substituted, a hydroxyl group or the like; R2 represents a piperidin-1,4-diyl or piperazin-1,4-diyl which may be substituted; R3 represents a bivalent group which is formed by removing two hydrogen atoms from a benzene ring or 6-membered aromatic heterocyclic ring which may have a substituent, provided that R3 is not a pyridazin-3,6-diyl; and R4 represents a group which is formed by removing one hydrogen atom from a benzene ring or 5- to 6-membered heterocyclic ring which may be substituted, provided that the substituent on the heterocyclic ring is not a phenylethyl group which may be substituted when Z is sulfur.
摘要翻译：由式（I）表示的化合物或其盐; 以及用于保护脑/神经元细胞或用于睡眠障碍的治疗剂的药剂，其包含所述化合物或盐：其中Z表示氧或硫; R1表示可被取代的芳基或杂环基，条件是R 1不是3-乙基-6-甲氧基-2-甲基-5-萘-1-基; R 1a表示氢原子，可被取代的烃基，羟基等; R2代表可被取代的哌啶-1,4-二基或哌嗪-1,4-二基; R3表示通过从可以具有取代基的苯环或6元芳族杂环除去2个氢原子而形成的二价基团，条件是R 3不是哒嗪-3,6-二基; 并且R 4表示通过从可以被取代的苯环或5-至6-元杂环除去一个氢原子而形成的基团，条件是杂环上的取代基不是Z时可以被取代的苯基乙基是硫。

5. 发明申请

US20100234389A1 AMIDE COMPOUND 审中-公开
标题翻译：酰胺化合物
公开(公告)号：US20100234389A1
公开(公告)日：2010-09-16
申请号：US12681854
申请日：2008-10-09
申请人： Masakuni Kori , Mitsunori Kouno
发明人： Masakuni Kori , Mitsunori Kouno
IPC分类号： A61K31/506 , C07D403/14 , A61K31/497 , C07D241/04 , A61K31/4965 , C07D413/12 , C07D403/12 , A61P25/22 , A61P25/24 , A61P29/00
CPC分类号： C07D213/75 , C07D213/74 , C07D231/40 , C07D237/20 , C07D241/20 , C07D261/14 , C07D295/205 , C07D401/12 , C07D403/12 , C07D413/12
摘要： An object of the present invention is to provide a novel fused-ring compound which has a FAAH inhibitory effect and is useful as an analgesic.The present invention relates to a compound represented by formula (I): wherein symbols are as defined in the specification, or salt thereof.
摘要翻译：本发明的目的是提供一种具有FAAH抑制作用并可用作止痛剂的新型稠环化合物。本发明涉及由式（I）表示的化合物：其中符号如说明书中所定义，或其盐。

6. 发明申请

US20090163508A1 AMIDE COMPOUND 审中-公开
标题翻译：酰胺化合物
公开(公告)号：US20090163508A1
公开(公告)日：2009-06-25
申请号：US12248730
申请日：2008-10-09
申请人： Masakuni KORI , Mitsunori Kouno
发明人： Masakuni KORI , Mitsunori Kouno
IPC分类号： A61K31/506 , C07D401/14 , C07D413/14 , C07D403/14 , A61K31/501 , A61K31/495 , A61P29/00 , A61P25/00 , A61K31/497 , A61K31/496 , C07D401/12 , C07D413/12
CPC分类号： C07D213/75 , C07D213/74 , C07D231/40 , C07D237/20 , C07D241/20 , C07D261/14 , C07D295/205 , C07D401/12 , C07D403/12 , C07D413/12
摘要： An object of the present invention is to provide a novel fused-ring compound which has a FAAH inhibitory effect and is useful as an analgesic.The present invention relates to a compound represented by formula (I): wherein symbols are as defined in the specification, or salt thereof.
摘要翻译：本发明的目的是提供一种具有FAAH抑制作用并可用作止痛剂的新型稠环化合物。本发明涉及由式（I）表示的化合物：其中符号如说明书中所定义，或其盐。

7. 发明授权

US5560450A Self-scanning checkout device 失效
标题翻译：自扫描结帐装置
公开(公告)号：US5560450A
公开(公告)日：1996-10-01
申请号：US376870
申请日：1995-01-23
申请人： Mitsunori Kouno
发明人： Mitsunori Kouno
IPC分类号： A47F9/04 , G07G1/00 , G07G1/12
CPC分类号： A47F9/046 , G07G1/0045
摘要： A self-scanning checkout device includes a stationary scanner for reading an article code affixed to an article, and a cash register disposed adjacent to the stationary scanner, for performing a settlement process based on article codes sequentially supplied from the stationary scanner. The cash register has a printing unit for printing a result of the settlement process. In particular, the cash register has a housing section having an article table which is exposed at a top of the housing section and on which an article whose article code is difficult to read by the stationary scanner is placed. The housing section is provided for receiving the printing unit below the article table and permitting the printing unit to be freely exposed.
摘要翻译：自动扫描结算装置包括用于读取固定在物品上的物品代码的固定式扫描器和与固定扫描器相邻设置的收银机，用于基于从固定扫描器顺序提供的物品代码进行结算处理。收银机具有用于打印结算过程结果的打印单元。特别地，收银机具有一个具有一个物品台的外壳部分，该物品台被暴露在该外壳部分的顶部，并且在其上放置一个由固定式扫描仪难以读取的物品的物品。壳体部分被设置用于接收在物品台下方的打印单元，并允许打印单元自由曝光。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式